CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Funding and Management of Naloxone Programs in Canada

Last updated: March 13, 2018
Project Number: ES0319-000
Product Line: Environmental Scans
Research Type: Drug
Result type: Report

This Environmental Scan presents how naloxone is made available in Canadian provinces and territories. The key objectives of this Environmental Scan are to answer the following questions:

  • How are take-home naloxone programs managed and funded?
  • How are take-home naloxone kits distributed?
  • What are the contents of publicly funded take-home naloxone kits?
  • How are public drug plans involved in the coverage and distribution of naloxone?
  • Which first responders carry and administer naloxone?

This Environmental Scan does not provide a comprehensive review of the naloxone programs, nor does it appraise the effectiveness of these programs or policies. The Environmental Scan only presents a profile of how naloxone is made available in each jurisdiction; that is, it provides examples of the operation, oversight, and funding of take-home naloxone programs, and if (and how) public drug plans and first responders provide naloxone.